|Min SIP Amount||Not Supported|
|NAV||₹34.00 (27 Nov 2020)|
|Fund Started||29 Jul 2019|
|Fund Size||₹12 Cr|
|Divi's Laboratories Ltd.||Healthcare||Equity||5.3%|
|Avenue Supermarts Ltd.||Services||Equity||4.4%|
|Tata Consumer Products Ltd.||FMCG||Equity||3.9%|
|Info Edge (India) Ltd.||Services||Equity||3.3%|
|Pidilite Industries Ltd.||Chemicals||Equity||3.2%|
|Aurobindo Pharma Ltd.||Healthcare||Equity||2.9%|
|Shree Cement Ltd.||Construction||Equity||2.8%|
|Apollo Hospitals Enterprise Ltd.||Healthcare||Equity||2.7%|
|Colgate-Palmolive (India) Ltd.||FMCG||Equity||2.6%|
Nippon India ETF Sensex Next 50 Regular Growth is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 29 Jul 2019. Mehul Dama is the Current Fund Manager of Nippon India ETF Sensex Next 50 Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹12 Cr and the Latest NAV as of 27 Nov 2020 is ₹34.00.
The Nippon India ETF Sensex Next 50 Regular Growth is rated Moderately High risk. Minimum Lumpsum Investment is 5000.
The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the S&P BSE SENSEX Next 50 Index before expenses, subject to tracking errors.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.